# Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial

> **NCT02418572** · PHASE3 · TERMINATED · sponsor: **Fundacion Dexeus** · enrollment: 290 (actual)

## Conditions studied

- Infertility
- Poor Ovarian Response

## Interventions

- **DRUG:** Testosterone gel
- **DRUG:** Placebo gel

## Key facts

- **NCT ID:** NCT02418572
- **Lead sponsor:** Fundacion Dexeus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2023-12
- **Final completion:** 2024-02
- **Target enrollment:** 290 (ACTUAL)
- **Why stopped:** Having reached the sample size described for the interim analysis and having seen the post-interim results, the sponsor has decided to stop the trial due to futility.
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418572, "Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02418572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*